American Healthcare REIT, Inc. $AHR Position Trimmed by Intech Investment Management LLC

Intech Investment Management LLC trimmed its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 20.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 72,012 shares of the company’s stock after selling 18,713 shares during the quarter. Intech Investment Management LLC’s holdings in American Healthcare REIT were worth $2,646,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in AHR. New York State Common Retirement Fund lifted its position in American Healthcare REIT by 37.8% in the 1st quarter. New York State Common Retirement Fund now owns 47,000 shares of the company’s stock worth $1,424,000 after buying an additional 12,900 shares in the last quarter. Kingsview Wealth Management LLC acquired a new position in shares of American Healthcare REIT in the first quarter worth $364,000. Private Advisor Group LLC raised its holdings in shares of American Healthcare REIT by 8.5% during the first quarter. Private Advisor Group LLC now owns 33,614 shares of the company’s stock worth $1,019,000 after acquiring an additional 2,642 shares in the last quarter. Allianz Asset Management GmbH acquired a new stake in American Healthcare REIT during the first quarter valued at $2,687,000. Finally, Choreo LLC acquired a new position in American Healthcare REIT in the 1st quarter worth about $354,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at American Healthcare REIT

In other news, EVP Mark E. Foster sold 3,850 shares of the company’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total transaction of $161,276.50. Following the completion of the transaction, the executive vice president directly owned 59,100 shares in the company, valued at $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeffrey T. Hanson sold 20,010 shares of the firm’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $49.68, for a total transaction of $994,096.80. Following the completion of the sale, the director owned 21,798 shares in the company, valued at approximately $1,082,924.64. The trade was a 47.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 25,360 shares of company stock worth $1,229,398. Company insiders own 0.92% of the company’s stock.

American Healthcare REIT Stock Up 0.6%

AHR stock opened at $49.47 on Thursday. The stock has a market capitalization of $8.75 billion, a price-to-earnings ratio of 353.32, a price-to-earnings-growth ratio of 2.05 and a beta of 0.98. The company has a 50-day moving average of $43.93 and a two-hundred day moving average of $39.80. American Healthcare REIT, Inc. has a 52-week low of $26.40 and a 52-week high of $50.51. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.44 and a quick ratio of 0.44.

American Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th were issued a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a yield of 2.0%. American Healthcare REIT’s dividend payout ratio (DPR) is 714.29%.

Wall Street Analyst Weigh In

AHR has been the subject of several research reports. JMP Securities lifted their price target on American Healthcare REIT from $45.00 to $50.00 and gave the company a “market outperform” rating in a report on Friday, October 17th. Scotiabank boosted their target price on shares of American Healthcare REIT from $47.00 to $55.00 and gave the stock a “sector outperform” rating in a research report on Thursday, November 13th. Zacks Research upgraded shares of American Healthcare REIT from a “hold” rating to a “strong-buy” rating in a report on Friday, October 17th. UBS Group lifted their price objective on shares of American Healthcare REIT from $51.00 to $56.00 and gave the company a “buy” rating in a research note on Monday. Finally, Citigroup reissued an “outperform” rating on shares of American Healthcare REIT in a research report on Friday, October 17th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $50.60.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.